Exploring the association between somatic molecular features and tumor mutation burden in 513 non–small-cell lung cancer.

12101Background: Tumor mutation burden (TMB) is new clinical marker that predicts responses to immunotherapy, but the molecular basis of TMB is unknown. Understand the association between genomic l...